.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Accenture
AstraZeneca
Queensland Health
Johnson and Johnson
Merck
Argus Health
Chubb
Deloitte
Express Scripts

Generated: September 20, 2017

DrugPatentWatch Database Preview

Perphenazine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for perphenazine and what is the scope of perphenazine patent protection?

Perphenazine
is the generic ingredient in two branded drugs marketed by Ani Pharms Inc, Schering, Vintage Pharms, Pharm Assoc, Wilshire Pharms Inc, Watson Labs Inc, Sandoz, and Mylan Pharms Inc, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for perphenazine. Twelve suppliers are listed for this compound.

Summary for Generic Name: perphenazine

Tradenames:2
Patents:0
Applicants:8
NDAs:15
Drug Master File Entries: see list8
Suppliers / Packagers: see list12
Bulk Api Vendors: see list60
Clinical Trials: see list19
Therapeutic Class:Antipsychotics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:perphenazine at DailyMed

Pharmacology for Ingredient: perphenazine

Ingredient-typePhenothiazines
Drug ClassPhenothiazine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wilshire Pharms Inc
PERPHENAZINE
perphenazine
TABLET;ORAL205973-004Dec 17, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Schering
TRILAFON
perphenazine
TABLET, EXTENDED RELEASE;ORAL011361-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Schering
TRILAFON
perphenazine
CONCENTRATE;ORAL011557-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Assoc
PERPHENAZINE
perphenazine
CONCENTRATE;ORAL040360-001May 25, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Schering
TRILAFON
perphenazine
SYRUP;ORAL011294-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wilshire Pharms Inc
PERPHENAZINE
perphenazine
TABLET;ORAL205973-002Dec 17, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Inc
PERPHENAZINE
perphenazine
TABLET;ORAL207582-003Oct 17, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Schering
TRILAFON
perphenazine
TABLET;ORAL010775-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Schering
TRILAFON
perphenazine
TABLET;ORAL010775-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Watson Labs Inc
PERPHENAZINE
perphenazine
TABLET;ORAL207582-004Oct 17, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
AstraZeneca
Baxter
Fuji
Farmers Insurance
Cantor Fitzgerald
Deloitte
Colorcon
Novartis
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot